DAFNA CAPITAL MANAGEMENT LLC
10990 WILSHIRE BOULEVARD, LOS ANGELES, California, 90024, (310) 954-3200
Report Date: 03/31/2013
Position Statistics:
| Total Positions | 49 |
| New Positions | 6 |
| Increased Positions | 14 |
| Decreased Positions | 28 |
| Positions with Activity | 42 |
| Sold Out Positions | 6 |
| Total Mkt Value (in $ millions) |
57 |
Sector Weighting
| Basic Materials | |
| Capital Goods | |
| Conglomerates | |
| Consumer Cyclical | |
| Consumer/Non-Cyclical | |
| Energy | |
| Financial | |
| Healthcare | 99.73% |
| Services | 0.27% |
| Technology | 0% |
| Transportation | |
| Utilities |
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.
49 Positions as of 03/31/2013
| Company | Class | Value of Shares ($1,000s) |
Change in Value ($1,000s) | Change (%) | Shares Held |
|---|---|---|---|---|---|
| NOVADAQ TECHNOLOGIES INC | COM | 7,558 | -1,496 | (16.52) | 535,249 |
| PHARMACYCLICS INC | COM | 7,211 | -4,321 | (37.47) | 85,128 |
| INSULET CORP | COM | 4,877 | -24 | (0.49) | 163,981 |
| ATRICURE INC | COM | 4,292 | 1,223 | 39.84 | 477,401 |
| NXSTAGE MEDICAL INC | COM | 3,400 | 2,329 | 217.34 | 251,654 |
| ARIAD PHARMACEUTICALS INC | COM | 3,089 | 70 | 2.32 | 176,215 |
| GIVEN IMAGING | ORD SHS | 2,512 | -163 | (6.11) | 156,249 |
| PROTALIX BIOTHERAPEUTICS INC | COM | 1,911 | -274 | (12.52) | 366,866 |
| DYAX CORP | COM | 1,813 | 906 | 99.95 | 719,516 |
| CARDIONET INC | COM | 1,502 | -190 | (11.25) | 538,188 |
| CARDICA INC | COM | 1,372 | 560 | 68.97 | 1,072,069 |
| SPECTRANETICS CORP | COM | 1,027 | -137 | (11.79) | 52,362 |
| XENOPORT INC | COM | 1,023 | -178 | (14.82) | 191,262 |
| RIGEL PHARMACEUTICALS INC | COM NEW | 990 | -433 | (30.43) | 216,067 |
| RTI BIOLOGICS INC | COM | 933 | -447 | (32.4) | 217,058 |
| IMMUNOMEDICS INC | COM | 914 | 914 | New | 290,000 |
| ACHILLION PHARMACEUTICALS INC | COM | 905 | -124 | (12.05) | 116,800 |
| JOHNSON & JOHNSON | COM | 833 | New | 9,400 | |
| CUTERA INC | COM | 828 | -263 | (24.09) | 91,394 |
| BIOSPECIFICS TECHNOLOGIES CORP | COM | 816 | New | 51,692 |
Latest News Headlines
Lenovo Fiscal-Year Profit Beats Expectations 1:15AM ET - Dow Jones Business News
Lenovo 2012-13 Net Profit Beats Expectations 1:11AM ET - Dow Jones Business News
Farmers Demand GrainCorp Sell Assets Ahead of ADM Takeover 12:41AM ET - Dow Jones Business News
Berkshire Seeks ResCap, Ally Financial Report 12:35AM ET - Dow Jones Business News
UPDATE: Ford to End Australia Car Manufacturing 10:54PM ET - Dow Jones Business News
View All